EyePoint Pharmaceuticals, Inc.
SEC Filing List
EYPT CIK: 0001314102
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Eyepoint, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/22/2026 | |
| SCHEDULE 13G | 06/03/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Elston George | Eyepoint, Inc. | 05/27/2026 | |
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| 8-K | Current report filing | Eyepoint, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 05/13/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Eyepoint, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 8-K | Current report filing | Eyepoint, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/06/2026 | |
| DEF 14A | Definitive proxy statements | Eyepoint, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/27/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Eyepoint, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/27/2026 | |
| No record found. | |||||
| Load More | |||||
